Showing results (1901-1910 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|September 15, 2025
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TCMaxime Jullien, Eolia Brissot, Etienne Daguindau, et al.
Bone Marrow Transplantation|September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working PartyAgnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Bone Marrow Transplantation|October 23, 2025
Low-dose post-transplant cyclophosphamide in combination with low-dose alemtuzumab for graft-versus-host-disease prevention in mismatched unrelated allogeneic stem cell transplantation is associated with improved outcomes and reduced toxicityIoanna Lazana, Konstantinos Gkirkas, Ioannis Konstantellos, et al.
Bone Marrow Transplantation|October 22, 2025
Changing scenario in prevention and management of CMV infections in pediatric hematopoietic stem cell transplant patientsFederica Galaverna, Jan Styczynski, Per Ljungman
Bone Marrow Transplantation|July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMTSimona Iacobelli, Stefan Schönland, Linda Koster, et al.
Bone Marrow Transplantation|July 1, 1989
High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinomaL S Kaminer, S F Williams, J Beschorner, et al.
Bone Marrow Transplantation|July 1, 1989
Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approachesR Arnold, C R Bartram, B Heinze, et al.
Bone Marrow Transplantation|July 29, 2014
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myelomaT-F Wang, M A Fiala, A F Cashen, et al.
Bone Marrow Transplantation|July 29, 2014
The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myelomaS M Jaglowski, A S Ruppert, C C Hofmeister, et al.
Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.
Pageof 993